In fact,
when we talk about large trials, even though you had mentioned the discussion aroun
d genomics earlier, where the trials may be able to get smaller, for many new products today the incremental benefit over established therapies may be very small, and as a consequence the clinical
trials are very large: 15,000, 18,000 patients recruited a
s compared ...[+++] to 2,000 that you might have looked at in a traditional large clinical trial.